US EditionNeutrogena-owner Kenvue names Kirk Perry as interim CEO
Summary by Inside FMCG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
The company, which owns brands such as Tylenol, Listerine and Band-Aid, has been struggling since separating from Johnson & Johnson in May 2023.
·Brazil
Read Full Article
Neutrogena-owner Kenvue names Kirk Perry as interim CEO
Neutrogena-owner Kenvue has appointed Kirk Perry as interim CEO, effective immediately. Perry, a current member of Kenvue’s board, assumes the role following the departure of former CEO Thibaut Mongon. With more than 30 years of experience in the consumer goods and technology industries, Perry most recently served as president and CEO of Circana, a global provider of technology, data, and predictive analytics for the consumer, retail, and media…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
